Future directions in liver transplantation

Marie Csete*, Andre De Wolf

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


In conclusion, advanced knowledge of rejection and immunosuppression will almost certainly lead to the clinical use of xenografts in the not too distant future. The immunosuppressants currently used may be sufficient to control rejection, but new drugs are required to prevent hyperacute rejection and graft damage. The use of animals with genetically altered endothelial cells may eliminate hyperacute rejection.102,104.

Original languageEnglish (US)
Pages (from-to)93-109
Number of pages17
JournalSeminars in Anesthesia, Perioperative Medicine and Pain
Issue number2
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Future directions in liver transplantation'. Together they form a unique fingerprint.

Cite this